Casper Clemmensen

Casper Clemmensen currently serves as Chief Commercial Officer at Sanos Group A/S since January 2022. Previously, Casper held positions such as Business Development Director at NBCD A/S from September 2020 to present, and at Nordic Bioscience A/S from June 2016 to September 2020. With a background in Clinical Trial Management, Casper has extensive experience in the pharmaceutical industry, working at companies such as LEO Pharma A/S, Genmab, and Merck Serono. Casper's educational background includes a MSc in Pharmaceutical Sciences from University of Copenhagen, as well as additional certifications in clinical drug development and business management. Casper's expertise lies in oncology, particularly in Head and Neck Cancer research.